Experienced in WT1-Related Wilms Tumor Syndromes

Dr. Charles R. Dibb

Hematology Oncology
2828 E Barnett Rd, 
Medford, OR 

Experienced in WT1-Related Wilms Tumor Syndromes
2828 E Barnett Rd, 
Medford, OR 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Charles Dibb is a Hematologist Oncology provider in Medford, Oregon. Dr. Dibb is rated as an Experienced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Non-Hodgkin Lymphoma, Virilizing Ovarian Tumor, and Ovarian Carcinosarcoma.

His clinical research consists of participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Hematology Oncology
Licenses
Internal Medicine in OR
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

2828 E Barnett Rd, Medford, OR 97504
Call: 541-774-5853

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


4 Clinical Trials

Randomized, Double-Blind Phase III Study of Pazopanib vs. Placebo in Patients With Metastatic Renal Cell Carcinoma Who Have No Evidence of Disease Following Metastatectomy
Randomized, Double-Blind Phase III Study of Pazopanib vs. Placebo in Patients With Metastatic Renal Cell Carcinoma Who Have No Evidence of Disease Following Metastatectomy
Enrollment Status: Active_not_recruiting
Publish Date: September 22, 2025
Intervention Type: Procedure, Drug, Other
Study Drug: Pazopanib Hydrochloride
Study Phase: Phase 3
A Randomized Phase II/III Trial of Afatinib Plus Cetuximab Versus Afatinib Alone in Treatment-Naive Patients With Advanced, EGFR Mutation Positive Non-small Cell Lung Cancer (NSCLC)
A Randomized Phase II/III Trial of Afatinib Plus Cetuximab Versus Afatinib Alone in Treatment-Naive Patients With Advanced, EGFR Mutation Positive Non-small Cell Lung Cancer (NSCLC)
Enrollment Status: Active_not_recruiting
Publish Date: September 18, 2025
Intervention Type: Drug, Other, Biological
Study Drugs: Afatinib Dimaleate, Cetuximab
Study Phase: Phase 2/Phase 3
Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients With High-Risk, Hormone Receptor-Positive and HER2/Neu Negative Breast Cancer
Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients With High-Risk, Hormone Receptor-Positive and HER2/Neu Negative Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: December 27, 2024
Intervention Type: Drug, Other
Study Drugs: Anastrozole, Everolimus, Exemestane, Goserelin Acetate, Letrozole, Leuprolide Acetate, Tamoxifen Citrate
Study Phase: Phase 3
A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel With or Without Carboplatin for Node-Positive or High-Risk Node-Negative Triple-Negative Invasive Breast Cancer
A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel With or Without Carboplatin for Node-Positive or High-Risk Node-Negative Triple-Negative Invasive Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: June 03, 2024
Intervention Type: Drug, Other
Study Drugs: Carboplatin, Cyclophosphamide, Doxorubicin Hydrochloride, Paclitaxel
Study Phase: Phase 3
View 3 Less Clinical Trials
Similar Doctors
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Mujahid A. Rizvi
Hematology Oncology | Hematology | Oncology
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Mujahid A. Rizvi
Hematology Oncology | Hematology | Oncology

Asante

2825 E Barnett Rd, 
Medford, OR 
 (0.2 miles away)
541-789-7000
Languages Spoken:
English, Hindi, Urdu
See accepted insurances
Accepting New Patients
Offers Telehealth

Mujahid Rizvi is a Hematologist Oncology specialist and a Hematologist in Medford, Oregon. Dr. Rizvi is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Appendix Cancer, Reticuloendotheliosis, Hairy Cell Leukemia (HCL), Lynch Syndrome, and Bone Marrow Aspiration. Dr. Rizvi is currently accepting new patients.

Advanced in WT1-Related Wilms Tumor Syndromes
Dr. Brett A. Poisson
Hematology Oncology | Hematology | Oncology
Advanced in WT1-Related Wilms Tumor Syndromes
Dr. Brett A. Poisson
Hematology Oncology | Hematology | Oncology

Asante Three Rivers Medical Center LLC

500 Sw Ramsey Ave, 
Grants Pass, OR 
 (27.2 miles away)
541-472-7000
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Brett Poisson is a Hematologist Oncology specialist and a Hematologist in Grants Pass, Oregon. Dr. Poisson is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Waldenstrom Macroglobulinemia, Gaucher Disease Type 1, Gaucher Disease, and Gaucher Disease Type 3. Dr. Poisson is currently accepting new patients.

Advanced in WT1-Related Wilms Tumor Syndromes
Dr. Ashish D. Dwary
Hematology Oncology | Hematology | Oncology
Advanced in WT1-Related Wilms Tumor Syndromes
Dr. Ashish D. Dwary
Hematology Oncology | Hematology | Oncology

Asante Three Rivers Medical Center LLC

500 Sw Ramsey Ave, 
Grants Pass, OR 
 (27.2 miles away)
541-472-7000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Ashish Dwary is a Hematologist Oncology specialist and a Hematologist in Grants Pass, Oregon. Dr. Dwary is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Appendix Cancer, and Colorectal Cancer. Dr. Dwary is currently accepting new patients.

VIEW MORE WT1-RELATED WILMS TUMOR SYNDROMES DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Dibb's expertise for a condition
ConditionClose
      • Advanced
      • Breast Cancer
        Dr. Dibb is
        Advanced
        . Learn about Breast Cancer.
        See more Breast Cancer experts
      • Chronic Lymphocytic Leukemia (CLL)
        Dr. Dibb is
        Advanced
        . Learn about Chronic Lymphocytic Leukemia (CLL).
        See more Chronic Lymphocytic Leukemia (CLL) experts
      • Familial Prostate Cancer
        Dr. Dibb is
        Advanced
        . Learn about Familial Prostate Cancer.
        See more Familial Prostate Cancer experts
      • Multiple Myeloma
        Dr. Dibb is
        Advanced
        . Learn about Multiple Myeloma.
        See more Multiple Myeloma experts
      • Non-Hodgkin Lymphoma
        Dr. Dibb is
        Advanced
        . Learn about Non-Hodgkin Lymphoma.
        See more Non-Hodgkin Lymphoma experts
      • Ovarian Carcinosarcoma
        Dr. Dibb is
        Advanced
        . Learn about Ovarian Carcinosarcoma.
        See more Ovarian Carcinosarcoma experts
      View All 9 Advanced Conditions
      • Experienced
      • Acquired Hemophilia
        Dr. Dibb is
        Experienced
        . Learn about Acquired Hemophilia.
        See more Acquired Hemophilia experts
      • Adult Soft Tissue Sarcoma
        Dr. Dibb is
        Experienced
        . Learn about Adult Soft Tissue Sarcoma.
        See more Adult Soft Tissue Sarcoma experts
      • Agranulocytosis
        Dr. Dibb is
        Experienced
        . Learn about Agranulocytosis.
        See more Agranulocytosis experts
      • Astrocytoma
        Dr. Dibb is
        Experienced
        . Learn about Astrocytoma.
        See more Astrocytoma experts
      • Atypical Hemolytic Uremic Syndrome (aHUS)
        Dr. Dibb is
        Experienced
        . Learn about Atypical Hemolytic Uremic Syndrome (aHUS).
        See more Atypical Hemolytic Uremic Syndrome (aHUS) experts
      • Atypical Teratoid Rhabdoid Tumor (ATRT)
        Dr. Dibb is
        Experienced
        . Learn about Atypical Teratoid Rhabdoid Tumor (ATRT).
        See more Atypical Teratoid Rhabdoid Tumor (ATRT) experts
      View All 47 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile
      For Patients
      • Our Story
      • How MediFind Works
      • Conditions A-Z
      • Doctor Directory
      • Symptoms Directory
      • Procedures Directory
      • Treatment Directory
      • Drug Directory
      • Infusion Center Finder
      • FAQ
      • Contact Us
      For Providers and Practices
      • Claim Your Profile
      • Newsroom
      Business Solutions
      • Provider
      • Network Solutions
      Additional Resources
      • Consumer Health Data Privacy Policy
      • Privacy Policy
      • Terms of Use
      • Advertising Policy
      • Content Policy
      Subscribe to our newsletter

      Sign up to stay informed about MediFind and get wellness sent your way.

      Close

        By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

        Bullet PinMediFind
        Follow us on
        This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
        © 2025 All Rights Reserved